This document is a publication of a European patent application (EP3996817A1) related to antigen-binding protein constructs and their uses, filed by Mythic Therapeutics, Inc. The publication date is March 11, 2026, and it lists specific inventors and International Patent Classification (IPC) codes related to pharmaceuticals and protein chemistry.

As this is a patent publication, it does not impose direct compliance obligations or deadlines on regulated entities. However, it is relevant for companies operating in the biotechnology and pharmaceutical sectors, particularly those involved in drug development and intellectual property strategy, as it signals potential new technologies and patent landscapes.